These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 7680698)

  • 21. The effect of mutations in the MHC class I peptide binding groove on the cytotoxic T lymphocyte recognition of the Kb-restricted ovalbumin determinant.
    Nikolić-Zugić J; Carbone FR
    Eur J Immunol; 1990 Nov; 20(11):2431-7. PubMed ID: 2253683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes.
    Porgador A; Gilboa E
    J Exp Med; 1995 Jul; 182(1):255-60. PubMed ID: 7540653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delivery by Trypanosoma cruzi of proteins into the MHC class I antigen processing and presentation pathway.
    Garg N; Nunes MP; Tarleton RL
    J Immunol; 1997 Apr; 158(7):3293-302. PubMed ID: 9120286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modifying Antigen-Encapsulating Liposomes with KALA Facilitates MHC Class I Antigen Presentation and Enhances Anti-tumor Effects.
    Miura N; Akita H; Tateshita N; Nakamura T; Harashima H
    Mol Ther; 2017 Apr; 25(4):1003-1013. PubMed ID: 28236573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accessory cell requirements for saponin adjuvant-induced class I MHC antigen-restricted cytotoxic T-lymphocytes.
    Wu JY; Gardner BH; Kushner NN; Pozzi LA; Kensil CR; Cloutier PA; Coughlin RT; Newman MJ
    Cell Immunol; 1994 Apr; 154(1):393-406. PubMed ID: 7907530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Presentation of exogenous antigen with class I major histocompatibility complex molecules.
    Rock KL; Gamble S; Rothstein L
    Science; 1990 Aug; 249(4971):918-21. PubMed ID: 2392683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization.
    Carbone FR; Bevan MJ
    J Exp Med; 1989 Mar; 169(3):603-12. PubMed ID: 2784478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peptide affinity for MHC influences the phenotype of CD8(+) T cells primed in vivo.
    Ma H; Kapp JA
    Cell Immunol; 2001 Nov; 214(1):89-96. PubMed ID: 11902833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Auranofin, an immunosuppressive drug, inhibits MHC class I and MHC class II pathways of antigen presentation in dendritic cells.
    Han S; Kim K; Song Y; Kim H; Kwon J; Lee YH; Lee CK; Lee SJ; Ha N; Kim K
    Arch Pharm Res; 2008 Mar; 31(3):370-6. PubMed ID: 18409052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of macrophages in the induction and regulation of immunity elicited by exogenous antigens.
    Wijburg OL; van den Dobbelsteen GP; Vadolas J; Sanders A; Strugnell RA; van Rooijen N
    Eur J Immunol; 1998 Feb; 28(2):479-87. PubMed ID: 9521056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sensitization of MHC class I-restricted T cells to exogenous proteins: evidence for an alternative class I-restricted antigen presentation pathway.
    Martinez-Kinader B; Lipford GB; Wagner H; Heeg K
    Immunology; 1995 Oct; 86(2):287-95. PubMed ID: 7490131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An improved method of loading pH-sensitive liposomes with soluble proteins for class I restricted antigen presentation.
    Zhou F; Rouse BT; Huang L
    J Immunol Methods; 1991 Dec; 145(1-2):143-52. PubMed ID: 1765645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation of antigen specific CD8+ cytotoxic T cells following immunization with soluble protein formulated with novel glycoside adjuvants.
    Sheikh NA; Rajananthanan P; Attard GS; Morrow WJ
    Vaccine; 1999 Aug; 17(23-24):2974-82. PubMed ID: 10462232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of cytotoxic T lymphocytes by primary in vitro stimulation with peptides.
    Carbone FR; Moore MW; Sheil JM; Bevan MJ
    J Exp Med; 1988 Jun; 167(6):1767-79. PubMed ID: 2455012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epitope cleavage by Leishmania endopeptidase(s) limits the efficiency of the exogenous pathway of major histocompatibility complex class I-associated antigen presentation.
    Garcia MR; Graham S; Harris RA; Beverley SM; Kaye PM
    Eur J Immunol; 1997 Apr; 27(4):1005-13. PubMed ID: 9130657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MHC class I-mediated exogenous antigen presentation by exosomes secreted from immature and mature bone marrow derived dendritic cells.
    Utsugi-Kobukai S; Fujimaki H; Hotta C; Nakazawa M; Minami M
    Immunol Lett; 2003 Oct; 89(2-3):125-31. PubMed ID: 14556969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway.
    Rock KL; Clark K
    J Immunol; 1996 May; 156(10):3721-6. PubMed ID: 8621907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccination of class I major histocompatibility complex (MHC)-restricted murine CD8+ cytotoxic T lymphocytes towards soluble antigens: immunostimulating-ovalbumin complexes enter the class I MHC-restricted antigen pathway and allow sensitization against the immunodominant peptide.
    Heeg K; Kuon W; Wagner H
    Eur J Immunol; 1991 Jun; 21(6):1523-7. PubMed ID: 1904363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Manifestation of the MHC-unrestricted killing potential of a cytotoxic T cell clone requires activation in response to MHC-restricted self-presentation of antigen.
    Dick T; Staege MS; Reichmann G; Reske-Kunz AB
    J Immunol; 1993 Apr; 150(7):2575-83. PubMed ID: 8454844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delivery of protein antigen to the major histocompatibility complex class I-restricted antigen presentation pathway.
    Zhou F; Huang L
    J Drug Target; 1995; 3(2):91-109. PubMed ID: 7496732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.